• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析NLRP3炎性小体激活的启动阶段:分子见解与临床相关性

Unraveling the priming phase of NLRP3 inflammasome activation: Molecular insights and clinical relevance.

作者信息

Liao Yonghong, Kong Yueyao, Chen Hongyu, Xia Jing, Zhao Jianjun, Zhou Yang

机构信息

College of Veterinary Medicine, Southwest University, 402460 Chongqing, China; National Center of Technology Innovation for Pigs, 402460, Rongchang, Chongqing, China.

College of Veterinary Medicine, Southwest University, 402460 Chongqing, China.

出版信息

Int Immunopharmacol. 2025 Jan 27;146:113821. doi: 10.1016/j.intimp.2024.113821. Epub 2024 Dec 13.

DOI:10.1016/j.intimp.2024.113821
PMID:39674000
Abstract

The NLRP3 inflammasome plays a pivotal role in the innate immune response. Its activation involves a two-step mechanism that consists of priming and activation. The priming of the NLRP3 inflammasome is a vital initial phase necessary for its activation and subsequent involvement in the immune response, though its understanding varies across studies. Recent research has identified key proteins that influence the priming process, revealing a sophisticated regulatory network. This review provides a comprehensive review of the priming phase of NLRP3 inflammasome activation, with a particular focus on the underlying molecular mechanisms, including transcriptional regulation, orchestration of the phosphorylation status, deubiquitination and the relationships with the inflammation-associated diseases. Understanding the intricacies of NLRP3 inflammasome priming not only elucidates fundamental aspects of immune regulation, but also provides potential avenues for therapeutic intervention in inflammatory diseases.

摘要

NLRP3炎性小体在固有免疫反应中起关键作用。其激活涉及一个由启动和激活组成的两步机制。NLRP3炎性小体的启动是其激活及随后参与免疫反应所必需的重要初始阶段,不过不同研究对其的理解有所不同。最近的研究已鉴定出影响启动过程的关键蛋白,揭示了一个复杂的调控网络。本综述全面回顾了NLRP3炎性小体激活的启动阶段,特别关注潜在的分子机制,包括转录调控、磷酸化状态的调控、去泛素化以及与炎症相关疾病的关系。了解NLRP3炎性小体启动的复杂性不仅能阐明免疫调节的基本方面,还为炎症性疾病的治疗干预提供了潜在途径。

相似文献

1
Unraveling the priming phase of NLRP3 inflammasome activation: Molecular insights and clinical relevance.解析NLRP3炎性小体激活的启动阶段:分子见解与临床相关性
Int Immunopharmacol. 2025 Jan 27;146:113821. doi: 10.1016/j.intimp.2024.113821. Epub 2024 Dec 13.
2
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma.NLRP3 炎性小体的激活:一个谜团包裹着另一个谜团。
J Leukoc Biol. 2020 Sep;108(3):937-952. doi: 10.1002/JLB.3MR0720-513R. Epub 2020 Aug 3.
3
Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation.泛素连接酶的调控:调节NLRP3炎性小体的激活
Front Biosci (Landmark Ed). 2025 Mar 19;30(3):25970. doi: 10.31083/FBL25970.
4
[Regulation of the NLRP3 inflammasome].[NLRP3炎性小体的调控]
Med Sci (Paris). 2018 Jan;34(1):47-53. doi: 10.1051/medsci/20183401013. Epub 2018 Jan 31.
5
The roles of ubiquitination and deubiquitination of NLRP3 inflammasome in inflammation-related diseases: A review.NLRP3 炎性小体泛素化和去泛素化在炎症相关疾病中的作用:综述。
Biomol Biomed. 2024 Jan 8;24(4):708-721. doi: 10.17305/bb.2023.9997.
6
NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation.NLRP3 磷酸化是炎症小体激活的必要初始事件。
Mol Cell. 2017 Oct 5;68(1):185-197.e6. doi: 10.1016/j.molcel.2017.08.017. Epub 2017 Sep 21.
7
Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies.解析 NLRP3 炎性小体在过敏性炎症中的作用:对新型治疗方法的启示。
Front Immunol. 2024 Jul 26;15:1435892. doi: 10.3389/fimmu.2024.1435892. eCollection 2024.
8
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1.药物抑制 IKKβ 可减弱人髓系细胞系 THP-1 中的 NLRP3 炎性小体的初次激活。
Biochem Biophys Res Commun. 2021 Mar 19;545:177-182. doi: 10.1016/j.bbrc.2021.01.051. Epub 2021 Feb 6.
9
PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.Spata2-CYLD 通过去泛素化 PLK4 抑制中心体处 NEK7 介导的 NLRP3 炎性小体激活。
EMBO J. 2020 Jan 15;39(2):e102201. doi: 10.15252/embj.2019102201. Epub 2019 Nov 25.
10
NLRP3 inflammasome in cardiovascular diseases: an update.心血管疾病中的NLRP3炎性小体:最新进展
Front Immunol. 2025 Feb 26;16:1550226. doi: 10.3389/fimmu.2025.1550226. eCollection 2025.

引用本文的文献

1
Investigating Protective Effect of Suspension of Paeoniflorin in Combination with Curcumin Against Acute Liver Injury Based on Inhibition of TLR4/NF-κB/NLRP3 Inflammatory Pathway.基于抑制TLR4/NF-κB/NLRP3炎症通路探讨芍药苷与姜黄素混悬液对急性肝损伤的保护作用
Int J Mol Sci. 2025 Jun 30;26(13):6324. doi: 10.3390/ijms26136324.
2
NLRP3 Inflammasome and Inflammatory Response in Aging Disorders: The Entanglement of Redox Modulation in Different Outcomes.NLRP3炎性小体与衰老相关疾病中的炎症反应:氧化还原调节在不同结果中的纠结
Cells. 2025 Jun 29;14(13):994. doi: 10.3390/cells14130994.
3
Anesthesia-induced developmental neurotoxicity in the setting of systemic inflammation: the role of microglia.
全身炎症背景下麻醉诱导的发育神经毒性:小胶质细胞的作用
Exp Biol Med (Maywood). 2025 May 16;250:10549. doi: 10.3389/ebm.2025.10549. eCollection 2025.
4
Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations.从NLRP3炎性小体视角看肺纤维化:作用机制与潜在治疗新进展
Front Immunol. 2025 May 5;16:1593729. doi: 10.3389/fimmu.2025.1593729. eCollection 2025.
5
NLRP3 inflammasome: structure, mechanism, drug-induced organ toxicity, therapeutic strategies, and future perspectives.NLRP3炎性小体:结构、机制、药物诱导的器官毒性、治疗策略及未来展望
RSC Med Chem. 2025 May 13. doi: 10.1039/d5md00167f.
6
COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case-Control Study.新冠肺炎在肥胖患者中比在其他慢性病患者中诱导更强的NLRP3炎性小体激活:一项病例对照研究。
Int J Mol Sci. 2025 Feb 12;26(4):1541. doi: 10.3390/ijms26041541.